Information Provided By: 
Fly News Breaks for February 22, 2019
ALXN
Feb 22, 2019 | 07:12 EDT
Guggenheim analyst Yatin Suneja initiated Alexion with a Neutral rating and $135 price target, stating that he believes much of the growth in Soliris's approved indications is abating and the launch of next-gen Ultomiris could further taper some of the remaining growth. He also sees a lack of meaningful catalysts in the next 12 months.
News For ALXN From the Last 2 Days
There are no results for your query ALXN
